FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to an aqueous composition consisting of moxifloxacin hydrochloride and sodium chloride and comprising from 0.04% to 0.4% (mas/vol) (as measured for the amount of moxifloxacin) of moxifloxacin hydrochloride and from 0.4% to 0.9% (mas/vol) of sodium chloride. Also, invention relates to applying this composition with the aim for preparing a medicinal agent used for prophylaxis or treatment of bacterial infections in humans or animals. Invention provides stability of the prepared moxifloxacin solution as moxifloxacin hydrochloride in the presence of iron ions.
EFFECT: improved properties of compositions.
6 cl.
| Title | Year | Author | Number |
|---|---|---|---|
| MOXIFLOXACIN AQUEOUS FORMULATION FOR PARENTERAL INTRODUCTION | 2012 |
|
RU2472507C1 |
| ENROFLOXACIN INJECTION OR INFUSION SOLUTION | 1995 |
|
RU2147225C1 |
| ENROFLOXACIN BASED TREATMENT OF MASTITIS | 2005 |
|
RU2413514C2 |
| THERAPY OF RESPIRATORY APPARATUS BACTERIOSIS BY LOCAL APPLICATION OF FLUOROQUINOLONES | 2004 |
|
RU2373937C9 |
| INJECTION SOLUTION FOR TREATING VIRAL DISEASES SPECIFIED IN H1N1, H3N2, H5N1 INFLUENZA, TICK-BORNE ENCEPHALITIS AND WEST NILE FEVER | 2013 |
|
RU2574007C2 |
| COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
| OPHTHALMIC OINTMENT FORMULATION AND METHOD FOR PREPARING SAME | 2012 |
|
RU2531937C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2435583C1 |
| METHOD FOR STABILIZING INFUSION CIPROFLOXACIN SOLUTION | 2002 |
|
RU2229884C2 |
| AQUEOUS COMPOSITIONS CONTAINING ARBEKACINE | 2012 |
|
RU2604767C2 |
